|
Diabetes Care, Vol 19, Issue 11 1265-1268, Copyright © 1996 by American Diabetes Association
Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM
AM Carter, MW Mansfield, MH Stickland and PJ Grant
Unit of Molecular Vascular Medicine, Research School of Medicine, University of Leeds, U.K. angelac@pathology.leeds.ac.uk
OBJECTIVE: To investigate the association of a G/A polymorphism at position
-455 of the beta-fibrinogen gene and fibrinogen levels in the development
of coronary artery disease (CAD) in subjects with NIDDM. RESEARCH DESIGN
AND METHODS: In 187 Caucasian subjects with NIDDM, presence of CAD was
taken as a clinical history of angina, myocardial infarction, coronary
angioplasty, or coronary artery bypass grafting, confirmed from medical
case notes. RESULTS: Fibrinogen levels were significantly higher in
subjects with CAD (n = 38, 3.41 [3.12-3.73] g/l) than those without (n =
149, 2.99 [2.87-3.11] g/l, P = 0.004 [geometric mean, 95% CI]). Comparing
the genotype frequencies by chi 2 testing, there was a significant
difference between subjects with CAD (GG = 0.84, GA + AA = 0.16) and those
without (GG = 0.64, GA + AA = 0.36, P = 0.02). In a logistic regression
model, including age, BMI, cholesterol, sex, smoking, triglycerides, and
plasminogen activator inhibitor antigen as covariates, genotype and
fibrinogen levels were significantly associated with CAD. The odds ratio
for having CAD in individuals homozygous for the G allele compared with
those possessing the A allele was 1.77 (1.08-2.90), P = 0.03; and for an
increase of 1 g/l in fibrinogen levels was 1.60 (1.00-2.60), P = 0.05.
CONCLUSIONS: These data suggest a relationship between the -455 G/A
beta-fibrinogen gene polymorphism and the development of CAD in subjects
with NIDDM. This relationship was not associated with variations in
fibrinogen levels, suggesting that this polymorphism may be in linkage with
a polymorphism within the coding region of the beta-fibrinogen gene, which
results in an alteration in the stability of the fibrin clot.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Koch, P. Hoppmann, J. Biele, J. C. Mueller, A. Schomig, and A. Kastrati
Fibrinogen Genes and Myocardial Infarction: A Haplotype Analysis
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2008;
28(4):
758 - 763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Al-Barjas, R. Ariens, P. Grant, and J. A. Scott
Raised Plasma Fibrinogen Concentration in Patients With Abdominal Aortic Aneurysm
Angiology,
October 1, 2006;
57(5):
607 - 614.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Soria, L. Almasy, J. C. Souto, A. Buil, M. Lathrop, J. Blangero, and J. Fontcuberta
A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2005;
25(6):
1287 - 1292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Scott, R. A.S. Ariens, and P. J. Grant
Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2004;
24(9):
1558 - 1566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Mills, R. A.S. Ariens, M. W. Mansfield, and P. J. Grant
Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease
Circulation,
October 8, 2002;
106(15):
1938 - 1942.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iacoviello, E. Ciccarone, and M. B. Donati
Review: The genetics of macrovascular disease in diabetes
The British Journal of Diabetes & Vascular Disease,
September 1, 2002;
2(5):
364 - 368.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.D. Mills, M.W. Mansfield, and P.J. Grant
Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease
Eur. Heart J.,
August 2, 2002;
23(16):
1276 - 1281.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Iacoviello, M. Vischetti, F. Zito, and M. Benedetta Donati
Genes Encoding Fibrinogen and Cardiovascular Risk
Hypertension,
November 1, 2001;
38(5):
1199 - 1203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Williams and P. F. Bray
Genetics of Arterial Prothrombotic Risk States
Experimental Biology and Medicine,
May 1, 2001;
226(5):
409 - 419.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. A. Lane and P. J. Grant
Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
Blood,
March 1, 2000;
95(5):
1517 - 1532.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Tracy, A. M. Arnold, W. Ettinger, L. Fried, E. Meilahn, and P. Savage
The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly : Results From the Cardiovascular Health Study
Arterioscler. Thromb. Vasc. Biol.,
July 1, 1999;
19(7):
1776 - 1783.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Diabetes Association.
|
|
| |
|